Ifosfamide 1gm with 3 ampoules of 200mg Mesna Injection
Ifosfamide 1gm with 3 ampoules of 200mg Mesna Injection is an Anti Cancer drug. It is used to treat various types of cancer such as testicular cancer. The universal name of this drug is Holoxan with Uromitexan by which it is available in pharmacies.
The two components Mesna and Ifosfamide are combined band converted into acrolein which is a urotoxic metabolite. This then fights the cancer cells in the body and removes lumps in testicles.
A product that might react with Ifosfamide 1gm with 3 ampoules of 200mg Mesna Injection and produce negative effects in the body is Nalidixic Acid. Avoid consuming anything that is Nalidixic acid-based.
1. What is Holoxan with Uromitexan?
Holoxan with Uromitexan is an oncology combination containing ifosfamide 2 g with six ampoules of mesna 200 mg injection. Ifosfamide is an alkylating chemotherapy medicine, while mesna is used as a protective agent to help reduce ifosfamide-associated urinary tract toxicity.
2. What is Holoxan with Uromitexan used for?
Ifosfamide is used in combination with other anti-cancer medicines for certain cancers, including germ cell testicular cancer in specific treatment settings. The exact indication depends on the applicable prescribing information and oncology treatment protocol.
3. What is the role of Uromitexan (Mesna) in this combination?
Uromitexan contains mesna, which helps protect the urinary tract from the urotoxic effects of ifosfamide. Mesna is specifically used to reduce the incidence or severity of ifosfamide-induced hemorrhagic cystitis.
4. How is Holoxan with Uromitexan administered?
The combination is administered under the supervision of qualified healthcare professionals. Ifosfamide is given by intravenous infusion, while mesna is administered according to the prescribed protective regimen. Dosage, timing and treatment duration are determined by the treating oncologist.
5. What are the possible side effects of Holoxan with Uromitexan?
Ifosfamide may cause adverse effects such as nausea, vomiting, reduced blood-cell counts, kidney toxicity and nervous-system effects, while mesna may also cause reactions such as nausea, headache or hypersensitivity reactions. Patients require appropriate medical monitoring during treatment.